Skip to main content
. 2016 Dec 27;61(1):e01763-16. doi: 10.1128/AAC.01763-16

FIG 3.

FIG 3

The effect of amikacin-fosfomycin combination therapy on the density of resistant bacterial populations of a P. aeruginosa clinical isolate (PA SAT 290) in an HFIM simulating pharmacokinetic decay of peak concentrations of 300 mg/liter amikacin–1,200 mg/liter fosfomycin in comparison with growth with monotherapy with each antibiotic.